Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.…
Tenon Medical (TNON) Q3 2026 Earnings Call Transcript
Tenon Medical (NASDAQ: TNON) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 26 employees.
The shares were at 0.8972 USD on 20 November 2026, down 22.0% over 52 weeks. Its 52-week range is 0.1250 USD to 17.84 USD: the price is 95.0% below the high and 617.8% above the low.
Its market capitalisation is 2.41M USD.
Tenon Medical reports return on equity of -249.1%, an operating margin of -228.0% and revenue up 126.8% year over year.
Its debt exceeds its cash by 4.00M USD, a debt-to-equity ratio of 0.03. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. The next earnings report is expected on 18 March 2027.